Literature DB >> 6721889

Acid labile alpha-interferon in sera and synovial fluids from patients with juvenile arthritis.

A M Arvin, J J Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721889     DOI: 10.1002/art.1780270517

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  5 in total

Review 1.  Emerging concepts of type I interferons in SLE pathogenesis and therapy.

Authors:  Antonios Psarras; Miriam Wittmann; Edward M Vital
Journal:  Nat Rev Rheumatol       Date:  2022-09-12       Impact factor: 32.286

2.  Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.

Authors:  M T Aguado; J D Lambris; G C Tsokos; R Burger; D Bitter-Suermann; J D Tamerius; F J Dixon; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 3.  Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation.

Authors:  J B Weinberg
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

Review 4.  Human natural interferon-alpha producing cells.

Authors:  P Fitzgerald-Bocarsly
Journal:  Pharmacol Ther       Date:  1993-10       Impact factor: 12.310

5.  Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile.

Authors:  A M Yee; J P Buyon; Y K Yip
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.